Ayesda Bio surveyed professionals across the life sciences sector to understand the challenges and trends shaping their work. The findings paint a picture of an industry navigating significant headwinds while embracing transformative technologies.
Key Themes
Several themes emerged consistently from the survey responses, reflecting the pressures and opportunities that life sciences professionals are experiencing across disciplines and geographies.
- Funding pressures: Budget constraints and funding uncertainty continue to affect research programmes, particularly in early-stage development and academic research. Professionals report increasing pressure to demonstrate ROI earlier in the development process.
- Supply chain challenges: Ongoing disruptions to reagent supply, equipment availability, and manufacturing capacity are forcing organisations to rethink their operational resilience and supplier relationships.
- AI and automation: The adoption of artificial intelligence and automation tools is accelerating across drug discovery, clinical trial design, and data analysis. However, there remains significant variation in how organisations are integrating these technologies — and concerns about data quality and regulatory acceptance persist.
- Advances in genomics: Continued progress in genomics and personalised medicine is creating new opportunities for targeted therapies, companion diagnostics, and precision treatment approaches — but also raising questions about data privacy, access, and equity.
What This Means for Research
These trends have direct implications for how market research and expert engagement are conducted in the life sciences sector. As the landscape becomes more complex, the need for authentic, specialist insight — from professionals who are genuinely embedded in these challenges — becomes even more critical.
Our perspective: The value of a specialist network is never more apparent than in times of rapid change. When the questions are harder, the people you ask matter more.